BI 1815368
BI 1815368 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood
Clinical Trials (5)
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5